PURPOSE: To review outcomes of lesions diagnosed at core-needle breast biopsy as
atypical lobular hyperplasia (ALH) or lobular carcinoma in situ (LCIS). MATERIALS AND …

Lobular neoplasia including lobular carcinoma in situ (LCIS) and atypical lobular
hyperplasia (ALH) may be identified in breast core needle biopsies as incidental findings or …

Abstract BACKGROUND. Lobular neoplasia (LN), encompassing atypical lobular
hyperplasia (ALH) and lobular carcinoma in situ (LCIS), is often an incidental finding on core …

BACKGROUND: No consensus exists on the need to excise breast lesions that yield classic
lobular carcinoma in situ (LCIS) or atypical lobular hyperplasia (ALH)(known together as …

Purpose To assess the utility of precise radiologic and pathologic correlation for establishing
imaging-histologic concordance or discordance as a method to limit the number of patients …

OBJECTIVE. The purpose of this article is to determine the upgrade rate to ductal carcinoma
in situ (DCIS) or invasive carcinoma at excision at the same site after percutaneous breast …

PURPOSE: To retrospectively determine frequency of invasive cancer or ductal carcinoma in
situ (DCIS) at excisional biopsy in women with atypical lobular hyperplasia (ALH) or lobular …

Context.—Percutaneous image-guided core biopsy is increasingly becoming the method of
choice to evaluate impalpable breast lesions presenting with mammographically detected …

OBJECTIVE. The aims of our study were to determine the frequency of malignancy after
surgical excision of biopsy-proven lobular carcinoma in situ (LCIS) or atypical lobular …

Background The surgical management of lobular in-situ neoplasia (LN) identified by core
needle biopsy (CNB) is currently variable. Our institution has routinely excised LN on CNB …